Cerenion’s long-standing Chief Medical Officer, Dr. Jukka Kortelainen, MD, has been appointed as the Chief Executive Officer of Cerenion as of February 1st 2020. Dr. Kortelainen is one of the founders of the company and a key member of the team behind its success so far. Dr. Kortelainen also continues as the Chief Medical Officer of the company.
"I look forward to the approaching launch of our first product, Cerenion C-Trend(R), in Europe this year, and steering this now seasoned team to new strengths globally from there on", Dr. Kortelainen reports.
The former CEO, Dr. Timo Koskela, PhD, MSc (Econ.&Bus.Adm.), continues as an important member of the executive team as the company’s Chief Financial Officer.
"It has been my pleasure to steer the company from an academic research project to a new startup finding its footing. As the company is now about to dive into the world of medical professionals with its first product I hand over the helm to Dr. Kortelainen with complete confidence.", remarks Dr. Koskela.
The move, approved by the board of directors in January, represents an internal realignment by the company to best address business demands as it ramps up its operations towards the international medical device markets.
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy Elektroniikkatie 3 90590 Oulu FINLAND
Cerenion Oy Firdonkatu 2 T 63 00520 Helsinki FINLAND